CN104402946B — 卡格列净中间体及其无定形的制备方法
Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2018-01-02 · 8y expired
What this patent protects
本发明提供了卡格列净中间体及其无定形的制备方法,其中卡格列净无定形的制备方法的步骤包括通过将(1S)‑1,5‑脱氢‑1‑[3‑[[5‑(4‑氟苯基)‑2‑噻吩基]甲基]‑4‑甲基苯基]‑D‑葡萄糖醇在良性溶剂中加热溶清,然后滴加到快速搅拌的不良溶剂中,过滤析出的固体,得到无定形卡格列净。本发明的制备方法能够降低溶剂用量,所得产品易分离,而且,所得产品收率好、纯度高,方法操作简单。
USPTO Abstract
本发明提供了卡格列净中间体及其无定形的制备方法,其中卡格列净无定形的制备方法的步骤包括通过将(1S)‑1,5‑脱氢‑1‑[3‑[[5‑(4‑氟苯基)‑2‑噻吩基]甲基]‑4‑甲基苯基]‑D‑葡萄糖醇在良性溶剂中加热溶清,然后滴加到快速搅拌的不良溶剂中,过滤析出的固体,得到无定形卡格列净。本发明的制备方法能够降低溶剂用量,所得产品易分离,而且,所得产品收率好、纯度高,方法操作简单。
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.